← SynDRA
ONAMETOSTAT
SynDRA canonical compound SYN0039348 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | PRMT5 |
| Mechanism of action | protein arginine N-methyltransferase inhibitor |
All known targets
Mechanisms of action (all sources)
- protein arginine N-methyltransferase inhibitor
- PRMT5 INHIBITOR
Drug classes
Cross-references
Synonyms
- JNJ-64619178
- JNJ64619178
- UNII-N8VKI8FPW0
- N8VKI8FPW0
- CHEMBL4249337
- (1S,2R,3S,5R)-3-(2-(2-Amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol
- (1S,2R,3S,5R)-3-(2-(2-Amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo(2,3-d)pyrimidin-7-yl)cyclopentane-1,2-diol
- entane-1,2-diol
- Onametostat [INN]
- SCHEMBL18572106
- EX-A2791
- BDBM50462572
- NSC808507
- NSC-808507
- JNJ45031882
- HY-101564
- CS-0021720
- S8624
- A16861
- (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop
- (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop entane-1,2-diol
- 1,2-Cyclopentanediol, 3-(2-(2-amino-3-bromo-7-quinolinyl)ethyl)-5-(4-amino-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-, (1S,2R,3S,5R)-
- K8N
- JNJ 64619178
- RefChem:168239
- PRMT5 Inhibitor JNJ-64619178
- Protein Arginine Methyltransferase 5 Inhibitor JNJ-64619178
- MFCD31813596
- ONAMETOSTAT [WHO-DD]
- C22H23BrN6O2
- orb1308171
- SCHEMBL29352669
- SCHEMBL29485640
- GTPL11749
- GLXC-20551
- LID77226
- AKOS040741898
- AC-36269
- DA-64660
Look up ONAMETOSTAT in the interactive SynDRA portal →